Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing selectivity and metabolic stability. Also employed in agrochemicals to improve bioavailability and resistance to degradation. The trifluoromethyl group contributes to increased lipophilicity and membrane permeability, making it valuable in drug design.